ArticleFrontiers in rehabilitation sciences2026
Case Report: Improving gait and fatigue in multiple sclerosis through wearable electrical stimulation: a single-patient study.
Article in Frontiers in rehabilitation sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis (MS) is a chronic disorder of the central nervous system characterized by progressive impairments in gait, balance, coordination, and fatigue. The Exopulse Mollii Suit (EMS) has been recently introduced as a non-invasive method for delivering peripheral surface electrical stimulation to alleviate motor dysfunction in individuals with neurological disorders. This case study evaluated the effects of a 1-Month home-based EMS intervention on functional and biomechanical outcomes in a woman with relapsing-remitting MS. Specifically, a 53-year-old woman, clinically stable and not receiving pharmacological treatment, used the EMS suit every other day for 60-minute sessions over one month. Assessments were conducted at Baseline, Post-Session (after one EMS use), after 1-Month of therapy, and at Follow-Up (one month after therapy cessation). Clinical evaluations included the 6 Min Walk Test (6MWT), 10-Meter Walk Test (10MWT), Timed Up and Go (TUG), and Modified Fatigue Impact Scale (MFIS). Additionally, instrumented balance and strength assessments were performed using the Hunova robotic platform. Progressive improvements were observed in all clinical outcomes: 6MWT distance increased by 28 meters, gait speed improved by 14%, TUG times decreased, and MFIS scores reflected a 30% reduction in fatigue. Balance robotic evaluations showed improvements in postural control, center of pressure metrics, and stabilization times. Notably, improvements were observed after a single session, became more consistent after one month, and were partially sustained at Follow-Up, but a regression toward baseline was observed for some outcomes. Hence, the EMS appears to be a promising home-based intervention for improving gait, balance, and fatigue in MS. However, further studies should be performed to validate these findings in larger cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.